Metformin: effective in the prevention of new-onset type 2 diabetes?
Cardiovascular Research Institute, University of California, San Francisco, 505 Parnassus Avenue, L-1337, San Francisco, CA 94143-0130, USA. ddrown@pacific.net
Donna J
DJ
Drown
D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D008019:Life Style; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000150:complications; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D007004:Hypoglycemic Agents; D008687:Metformin